4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The Internationalization Challenge: Where to Access Innovation

      chapter-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Pharma innovation is becoming increasingly global, partly due to the lure of serving new markets, partly because of the need to access early new technology and talent wherever it emerges. Apart from the established centers of innovation in the United States, Europe and Japan, India, China and Singapore are rising attractors for global life science R&D. China as a pharma market and host of pharma R&D is highlighted as a case study, both from the angle of foreign R&D investors and from the perspective of indigenous Chinese players. Given the significant cost pressures in mature markets, reverse innovation in healthcare has drawn considerable attention by local governments.

          Related collections

          Most cited references21

          • Record: found
          • Abstract: not found
          • Article: not found

          Reverse innovation, emerging markets, and global strategy

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            The link between the West African Ebola outbreak and health systems in Guinea, Liberia and Sierra Leone: a systematic review

            Background An Ebola outbreak started in December 2013 in Guinea and spread to Liberia and Sierra Leone in 2014. The health systems in place in the three countries lacked the infrastructure and the preparation to respond to the outbreak quickly and the World Health Organisation (WHO) declared a public health emergency of international concern on August 8 2014. Objective The aim of this study was to determine the effects of health systems’ organisation and performance on the West African Ebola outbreak in Guinea, Liberia and Sierra Leone and lessons learned. The WHO health system building blocks were used to evaluate the performance of the health systems in these countries. Methods A systematic review of articles published from inception until July 2015 was conducted following the PRISMA guidelines. Electronic databases including Medline, Embase, Global Health, and the Cochrane library were searched for relevant literature. Grey literature was also searched through Google Scholar and Scopus. Articles were exported and selected based on a set of inclusion and exclusion criteria. Data was then extracted into a spreadsheet and a descriptive analysis was performed. Each study was critically appraised using the Crowe Critical Appraisal Tool. The review was supplemented with expert interviews where participants were identified from reference lists and using the snowball method. Findings Thirteen articles were included in the study and six experts from different organisations were interviewed. Findings were analysed based on the WHO health system building blocks. Shortage of health workforce had an important effect on the control of Ebola but also suffered the most from the outbreak. This was followed by information and research, medical products and technologies, health financing and leadership and governance. Poor surveillance and lack of proper communication also contributed to the outbreak. Lack of available funds jeopardised payments and purchase of essential resources and medicines. Leadership and governance had least findings but an overarching consensus that they would have helped prompt response, adequate coordination and management of resources. Conclusion Ensuring an adequate and efficient health workforce is of the utmost importance to ensure a strong health system and a quick response to new outbreaks. Adequate service delivery results from a collective success of the other blocks. Health financing and its management is crucial to ensure availability of medical products, fund payments to staff and purchase necessary equipment. However, leadership and governance needs to be rigorously explored on their main defects to control the outbreak.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Market versus technology drive in R&D internationalization: four different patterns of managing research and development

                Bookmark

                Author and article information

                Journal
                978-3-319-66833-8
                10.1007/978-3-319-66833-8
                Leading Pharmaceutical Innovation
                Leading Pharmaceutical Innovation
                How to Win the Life Science Race
                978-3-319-66832-1
                978-3-319-66833-8
                11 May 2018
                : 135-153
                Affiliations
                [5 ]ISNI 0000 0001 2156 6618, GRID grid.15775.31, Institute of Technology Management, , University of St. Gallen, ; St. Gallen, Switzerland
                [6 ]ISNI 0000 0001 0666 4420, GRID grid.434088.3, Faculty of Applied Chemistry, , Reutlingen University, ; Reutlingen, Germany
                [7 ]ISNI 0000 0001 1091 4533, GRID grid.6901.e, Department of Strategic Management, , Kaunas University of Technology, ; Kaunas, Lithuania
                [8 ]Novi, MI USA
                Article
                7
                10.1007/978-3-319-66833-8_7
                7121637
                f0bb3e2a-bb94-4d80-8d10-df290b57f986
                © Springer International Publishing AG, part of Springer Nature 2018

                This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

                History
                Categories
                Article
                Custom metadata
                © Springer International Publishing AG, part of Springer Nature 2018

                Comments

                Comment on this article